Skip to content
Stream360 Media

Zimbabwe Declines ‘One-Sided’ US Health Aid Deal Over Information Fears

Health funding illustration
The proposed American financial assistance would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years due to Washington's insistence on sensitive biological samples.

The decision became public after a government memo dated December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".

A government spokesman later stated that the US was seeking health data for scientific study and commercial gain while was not willing to share the resulting advantages from future treatments.

"We are forced to start the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has urged more negotiations to secure a deal agreeable to all parties so the nation's critical HIV treatment initiative can continue.

Broader Context

This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a similar health funding agreement after concerns were raised about the security of citizens' medical information.

After returning to office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

The agency had managed aid for the US government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to boost transparency and responsibility.

Based on reports, 16 nations in Africa have to date agreed to these new agreements, constituting more than $18.3bn in new funding.

Specifics of the Rejected Deal

The funds for Zimbabwe would have funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," Tremont added.

However, official spokesman Nick Mangwana said the arrangement was "unfair".

"Zimbabwe was being asked to provide its biological resources and data indefinitely, with no corresponding assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," Mangwana explained.

"In essence, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our people should a future disease outbreak emerge."

Sovereignty and Global Health

Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were upending systems already set up via the international health agency.

Mangwana gave as an example its Pandemic Benefit-Sharing scheme created to manage potential global health emergencies.

"This mechanism is intended to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."

Zimbabwe's reservations over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome continued discussions with our American counterparts on how subsequent co-operation could be structured in a way that honours the independence and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that negotiations should continue since much of the nation's Aids initiatives depended on external financing.

"If specific concerns arise, such as those relating to information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.

The halted deal highlights the continuing debate between receiving much-needed foreign assistance and protecting a country's data in an ever more interconnected world.

BW
The writer

Brittany Wells

A digital strategist with over a decade of experience in media and technology, specializing in brand storytelling and innovative marketing solutions.

Stream360 Media

Type to search articles.